產品與服務

Recombinant antibodies, unlike the traditional hybridoma antibodies, its unique advantages in customization, high-throughput production and large-scale antibody production. Due to their low lot-to-lot variability and high specificity, recombinant antibodies are being touted as the future of antibodies in research. This means the diverse set applications utilizing antibodies such as immunodiagnostics and other biologics-based analytical research can benefit greatly from recombinant antibodies. iReal Biotechnology provides a flexible, one-stop solution for recombinant antibody development needs.

The phage display is also a technology for the generation of high quality candidates for human and veterinary therapeutic applications.

• Immune library from immunized animals or donors
• High throughput screening system
• Recombinant antibody production (several formats available)